WENDER JOSEPH H 4
4 · IONIS PHARMACEUTICALS INC · Filed Nov 20, 2025
Insider Transaction Report
Form 4
WENDER JOSEPH H
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-18$24.42/sh+16,000$390,720→ 16,000 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-18−16,000→ 0 totalExercise: $24.42From: 2017-07-01Exp: 2026-06-30→ Common Stock (16,000 underlying)
Holdings
- 64,035(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/2026.